hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06290414, orgStudyIdInfo id: FDASU-Rec IM 112318, briefTitle: The Accuracy of Infrared Thermographic Imaging for Assessment of Periodontal Status, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-30, primaryCompletionDateStruct date: 2024-03-30, completionDateStruct date: 2024-07-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Ain Shams University, class: OTHER, descriptionModule briefSummary: The diagnosis and differentiation between periodontal diseases are currently based on the measuring and interpretation of full-mouth clinical and radiographic criteria. Thermography is a modern non-invasive imaging method in which the infrared radiation emitted by an object allows the mapping and analysis of the exact temperature distribution on the surface of the object. The produced thermal images correlate with variations in local blood supply and tissue metabolism. Thus, suggested to be a useful rapid and non-invasive tool for the diagnosis of periodontal diseases. However, the validity of this tool compared to standard tools should be evaluated., conditionsModule conditions: Periodontal Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 45, type: ESTIMATED, armsInterventionsModule interventions name: infrared thermal camera, outcomesModule primaryOutcomes measure: Determine the agreement of thermographic images for diagnosis of periodontal diseases, secondaryOutcomes measure: The temperature ranges for healthy periodontium, gingivitis and periodontitis, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Faculty of dentistry Ain Shams University, status: RECRUITING, city: Cairo, country: Egypt, contacts name: Shrouk N. Elboray, BDS, role: CONTACT, phone: +201065433857, email: shrouk.elboraay@dent.asu.edu.eg, contacts name: Mahetab M. AbdalWahab, lecturer, role: CONTACT, phone: +201115554490, email: mahetabmohamed@dent.asu.edu.eg, contacts name: Ola M. Ezzatt, professor, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06290401, orgStudyIdInfo id: 2023-0671, briefTitle: A Socio-ecological Approach for Improving Self-management in Adolescents With SCD, acronym: SC-Thrive, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2028-01-31, completionDateStruct date: 2028-06-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Children's Hospital Medical Center, Cincinnati, class: OTHER, collaborators name: Nemours Children's Health System, collaborators name: Emory University, collaborators name: Children's Hospital of Philadelphia, descriptionModule briefSummary: The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving care at 1 of 4 pediatric SCD clinics.The main question\[s\]it aims to answer are:* Does SCThrive improve patient activation?* Does SCThrive improve self-management behaviors, daily functioning, and decrease emergency room visits?* Are any improvements maintained 3 months after treatment?Participants will complete self-management related surveys before, after, and 3 months following their participation in an 8- week, virtual group intervention with an accompanying mobile app (SCThrive).Researchers will compare outcomes for participants who receive SCThrive and participants who receive uniform standard care (SCHealthED which = standard of care plus SCD educational text messages) to see if there are differences in patient activation, self-management behaviors, daily functioning, and emergency room visits., conditionsModule conditions: Anemia, Sickle Cell, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants will be allocated to SCThrive or SCHealthED (uniform standard care) using a randomized block design for age group (13-17 years of age or 18-21 years of age) with a predefined block size of 4., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Investigator and Outcomes assessors will not know the condition to which participants have been randomized., whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 310, type: ESTIMATED, armsInterventionsModule interventions name: SCThrive, interventions name: SCHealthED, outcomesModule primaryOutcomes measure: Patient Activation, secondaryOutcomes measure: Self-Management Behaviors, secondaryOutcomes measure: Daily Functioning, secondaryOutcomes measure: Emergency Room (ER) Visits, secondaryOutcomes measure: Self-Management Skills, secondaryOutcomes measure: Health-related quality of life, eligibilityModule sex: ALL, minimumAge: 13 Years, maximumAge: 21 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06290375, orgStudyIdInfo id: HSK21542-T-202, briefTitle: A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population., statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-08, primaryCompletionDateStruct date: 2024-03-08, completionDateStruct date: 2025-04-11, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Xizang Haisco Pharmaceutical Co., Ltd, class: INDUSTRY, descriptionModule briefSummary: This is a two- stage study. Stage I is a multicenter, open-label trial；Stage II was a multi-center, randomized, double-blind, placebo-controlled trial. About 250 maintenance peritoneal dialysis patients with moderate or above pruritus are planned to be enrolled., conditionsModule conditions: Pruritus, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 250, type: ESTIMATED, armsInterventionsModule interventions name: HSK21542 tablet, interventions name: Placebo, outcomesModule primaryOutcomes measure: Proportion of subjects with an improvement of ≥ 4points from baseline in the weekly average of the daily Worst Itch Numeric Rating Scale (WI-NRS) after 12 weeks of treatment., secondaryOutcomes measure: Change from baseline in subjects' quality of life (evaluated using the Skindex-10 scale ) after 12 weeks of treatment., secondaryOutcomes measure: Change from baseline in subjects' quality of life (evaluated using the 5-D itch scale) after 12 weeks of treatment., eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06290362, orgStudyIdInfo id: EgeTrial4, briefTitle: Exploring Digitalized Interventions for Stress and Problem Solving, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-04-16, primaryCompletionDateStruct date: 2021-07-30, completionDateStruct date: 2021-11-28, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-07, sponsorCollaboratorsModule leadSponsor name: Ege University, class: OTHER, descriptionModule briefSummary: Excessive and prolonged stress can have detrimental effects on both psychological and physiological health, compromising overall well-being and functioning. This study examines the impact of telepsychiatric group consultation using Instagram as an unexplored online social media platform on stress levels and problem-solving skills among young adults., conditionsModule conditions: Stress, conditions: Problem-solving, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: FACTORIAL, interventionModelDescription: The current 8-week randomized, single-blind factorial trial was conducted with a control group and one intervention group. Over eight weeks, participants received cognitive behavioral-based intervention through online sessions. Pre-/post-test and follow-up assessments employed., primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 54, type: ACTUAL, armsInterventionsModule interventions name: Cognitive Behavioural Theory-based group consultation, outcomesModule primaryOutcomes measure: Perceived Stress Scale (first evaluation with posttest), primaryOutcomes measure: Problem Solving Inventory (first evaluation with posttest), primaryOutcomes measure: Perceived Stress Scale (second evaluation with follow up), primaryOutcomes measure: Problem Solving Inventory (second evaluation with follow up), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ege University, city: İzmir, zip: 35100, country: Turkey, geoPoint lat: 38.41273, lon: 27.13838, hasResults: False
protocolSection identificationModule nctId: NCT06290349, orgStudyIdInfo id: DA5221_DM_III, briefTitle: Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-28, primaryCompletionDateStruct date: 2025-05-31, completionDateStruct date: 2025-11-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Dong-A ST Co., Ltd., class: INDUSTRY, descriptionModule briefSummary: This study evaluates the efficacy and safety of adding the SGLT-2 inhibitor DA5221-T to the combination therapy of DA5221-B1 and the DPP-4 inhibitor DA5221-B2 in patients with type 2 diabetes who have inadequate blood glucose control. The study focuses on assessing the effectiveness and safety of the triple combination therapy., conditionsModule conditions: Type 2 Diabetes, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 162, type: ESTIMATED, armsInterventionsModule interventions name: DA5221-T1, interventions name: DA5221-T2, interventions name: Placebo, interventions name: DA5221-B1, interventions name: DA5221-B2, outcomesModule primaryOutcomes measure: Change from the baseline in HbA1c (%) after 24 weeks, secondaryOutcomes measure: Change from the baseline in fasting plasma glucose(mg/dL) after 24 weeks, secondaryOutcomes measure: Change from the baseline in HbA1c response rate(<7.0%, <6.5%) after 24 weeks, secondaryOutcomes measure: Change from the baseline in weight after 24 weeks, eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Severance Hospital, Yonsei University college of Medicine, city: Seoul, country: Korea, Republic of, contacts name: Cha Bong Soo, Ph.D, role: CONTACT, email: BSCHA@yuhs.ac, geoPoint lat: 37.566, lon: 126.9784, hasResults: False
protocolSection identificationModule nctId: NCT06290323, orgStudyIdInfo id: 11/05/2022-9/VIII, briefTitle: Effects of Quadratus Lumborum Block on Lower Urinary System Symptoms, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-01-25, primaryCompletionDateStruct date: 2024-05-15, completionDateStruct date: 2024-05-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Muğla Sıtkı Koçman University, class: OTHER, descriptionModule briefSummary: The most common reason for applying to a hospital in the postoperative period due to the double J stent inserted during operations of the uteroscopic lithotripsy is reflected pain (T11-L2). The posterior approximation QL block (QL-P) is known to extend more easily to the thoracic paravertebral cavity or thoracolumbar plane, creating analgesia from T 7' to L 1'. The effects of double J catheter in patients are followed by 'Ureteral Stent Symptom Scoring Survey'. QL-P for postoperative analgesia after URS operations Our primary hypothesis in this prospective, randomized, controlled study is that the symptoms of the sub-urinary system associated with the DJS of the QL-P block will decrease. Our secondary hypotheses in the study are to investigate the effects of the unilateral QL-P block, made under ultrasound guidance, on pain scores that occur after ureteroscopic lithotripsy operations due to unilateral ureteral stones made under spinal anesthesia., conditionsModule conditions: Lower Urinary Tract Symptoms, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Patients with double J catheter inserted into ureteroscopic lithotripsy surgeries due to urethral stones, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, maskingDescription: The researcher evaluating the survey does not know which group the patients are., whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 154, type: ESTIMATED, armsInterventionsModule interventions name: Quadratus lumborum block, interventions name: Placebo, outcomesModule primaryOutcomes measure: Quadratus posterior block, secondaryOutcomes measure: Pain Score, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Mugla Sitki Kocman Training and Research Hospital, city: Mugla, zip: 48000, country: Turkey, geoPoint lat: 37.21807, lon: 28.3665, hasResults: False
protocolSection identificationModule nctId: NCT06290310, orgStudyIdInfo id: PAVELA, briefTitle: Assessment of Patient-ventilator Asynchrony by Electric Impedance Tomography, acronym: PAVELA, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-12, primaryCompletionDateStruct date: 2024-09-01, completionDateStruct date: 2024-09-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Kiskunhalas Semmelweis Hospital the Teaching Hospital of the University of Szeged, class: OTHER_GOV, collaborators name: Hochschule Furtwangen University, collaborators name: Budapest University of Technology and Economics, collaborators name: Szeged University, descriptionModule briefSummary: Patient-ventilator asynchrony (PVA) has deleterious effects on the lungs. PVA can lead to acute lung injury and worsening hypoxemia through biotrauma. Little is known about how PVA affects lung aeration estimated by electric impedance tomography (EIT). Artificial intelligence can promote the detection of PVA and with its help, EIT measurements can be correlated to asynchrony., conditionsModule conditions: Acute Lung Injury, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 10, type: ESTIMATED, armsInterventionsModule interventions name: EIT, interventions name: patient-ventilator asynchrony assessment, outcomesModule primaryOutcomes measure: distribution, secondaryOutcomes measure: connecting asysnchrony cycles with electric impedance tomography measurements, secondaryOutcomes measure: identifying unic electric impedance tomography signs of asynchrony, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Kiskunhalas Semmelweis Hopsital the Teaching Hospital of the University of Szeged, city: Kiskunhalas, zip: 6400, country: Hungary, contacts name: András Lovas, M.D. Ph.D., role: CONTACT, phone: 003677522000, phoneExt: 2045, email: landras@halasi-korhaz.hu, geoPoint lat: 46.43402, lon: 19.48479, hasResults: False
protocolSection identificationModule nctId: NCT06290284, orgStudyIdInfo id: 6322, briefTitle: Comparison Between Mini-midline and the Peripheral Intravenous Catheter, acronym: INSERT/2022, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-09-25, primaryCompletionDateStruct date: 2023-11-17, completionDateStruct date: 2023-12-28, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, class: OTHER, descriptionModule briefSummary: The goal of this randomized controlled trial is to investigate the difference between LPC (mini-midline) and PIVC (peripheral venous catheter) on the need of further venipuncture for blood withdrawal or placement of a new vascular access.The main questions it aims to answer are:* Whether the number of patients with LPC and PIVC differ in terms of repeated venipunctures;* Whether the number of patients with LPC and PIVC differ in terms of adverse events associated with the use of such vascular catheters.Researchers will compare the proportion of patients with repeated venipunctures between LPC and PIVC arms., conditionsModule conditions: Vascular Access Devices, conditions: Venous Puncture, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: The statistician will be provided an anonymized dataset., whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 294, type: ACTUAL, armsInterventionsModule interventions name: Long Peripheral Catheter, interventions name: Peripheral Intra-Venous Catheter, outcomesModule primaryOutcomes measure: Difference in proportion, secondaryOutcomes measure: Adverse events associated with use of LPC and PIVC, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, city: Milan, zip: 20122, country: Italy, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False
protocolSection identificationModule nctId: NCT06290245, orgStudyIdInfo id: P.T.REC/012/005045, briefTitle: PEP Buddy Impact on Breathing, Exercise, and Sleep Quality in COPD Patients, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2024-10, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: Exercise intolerance and sleeping problems are among the most common symptoms experienced by patients with chronic obstructive pulmonary disease (COPD), which is associated with lung dynamic hyperinflation (DH). There was evidence that positive expiratory pressure (PEP), which less costly devices could offer, could reduce DH.A positive expiratory pressure device improved COPD-related symptoms in more than 70% of patients with COPD.PEP buddy is an adjunct to current COPD therapies, such as inhalers and pulmonary rehabilitation. It provides a tool for self-management and breathing re-training, reducing dyspnea and improving quality of life., conditionsModule conditions: Pulmonary Disease, Chronic Obstructive, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 90, type: ESTIMATED, armsInterventionsModule interventions name: PEP Buddy, interventions name: aerobic exercise, outcomesModule primaryOutcomes measure: dyspnea, secondaryOutcomes measure: pulmonary function, secondaryOutcomes measure: exercise capacity, secondaryOutcomes measure: Sleep quality, secondaryOutcomes measure: Health-related quality of life (HRQoL), eligibilityModule sex: ALL, minimumAge: 55 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Physical Therapy, status: RECRUITING, city: Giza, state: Dokki, zip: 11432, country: Egypt, contacts name: Ebtesam N Nagy, role: CONTACT, phone: +201278141946, email: Dr.EbtesamNagy2@outlook.com, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06290219, orgStudyIdInfo id: CF23509A, briefTitle: The Effect of Platelet-rich Plasma Nasal Injection in the Treatment of Traumatic Olfactory Dysfunction, acronym: PRP, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-20, primaryCompletionDateStruct date: 2024-09-30, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Taichung Veterans General Hospital, class: OTHER, descriptionModule briefSummary: The purpose of this study is to explore the efficacy of injecting high-concentration platelet plasma combined with hyaluronic acid into the nasal olfactory mucosa in the treatment of traumatic anosmia., conditionsModule conditions: Traumatic Olfactory Nerve Injury With Anosmia (Diagnosis), conditions: Effect of Drug, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: platelet-rich plasma combined with hyaluronic acid, interventions name: Zinc Gluconate 10 MG Oral Tablet, interventions name: 4 bottles of phenyl ethyl alcohol, lemon, eucalyptus, and clove oil, outcomesModule primaryOutcomes measure: phenyl ethyl alcohol odor detection threshold test, primaryOutcomes measure: traditional Chinese version of University of Pennsylvania Smell Identification Test (TC-UPSIT), secondaryOutcomes measure: Visual Analogue Scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Taichung Veterans General Hospital, city: Taichung, zip: 40705, country: Taiwan, contacts name: Rong-San Jiang, MD, PhD, role: CONTACT, phone: 800-555-5555, phoneExt: 4088, email: rsjiang@vghtc.gov.tw, contacts name: Kai-Li Liang, MD, role: CONTACT, phone: +886423592525, phoneExt: 82620, email: kellyliang1107@gmail.com, contacts name: Rong-San Jiang, MD, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 24.1469, lon: 120.6839, hasResults: False